Healthcare stocks were trading with losses, with the S&P BSE Healthcare index decreasing 222.47 points or 0.93% at 23610.57 at 13:51 IST.
Among the components of the S&P BSE Healthcare index, Bliss GVS Pharma Ltd (down 8.26%), Solara Active Pharma Sciences Ltd (down 6.38%),Krishna Institute of Medical Sciences Ltd (down 5.55%),Syncom Formulations (India) Ltd (down 4.91%),Take Solutions Ltd (down 3.98%), were the top losers. Among the other losers were Albert David Ltd (down 3.7%), Morepen Laboratories Ltd (down 3.69%), SMS Pharmaceuticals Ltd (down 3.32%), Nectar Lifescience Ltd (down 3.31%), and Panacea Biotec Ltd (down 3.24%).
On the other hand, Wockhardt Ltd (up 6.8%), Gland Pharma Ltd (up 1.51%), and Abbott India Ltd (up 1.33%) turned up.
At 13:51 IST, the S&P BSE Sensex was up 182.25 or 0.32% at 58015.22.
The Nifty 50 index was up 24.7 points or 0.14% at 17301.
The S&P BSE Small-Cap index was down 344.57 points or 1.24% at 27403.73.
The S&P BSE 150 Midcap Index index was down 38.74 points or 0.46% at 8345.07.
On BSE,866 shares were trading in green, 2538 were trading in red and 150 were unchanged.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU